BSP is a contract development and manufacturing organization (CDMO) focused on the development and manufacturing of anticancer drugs with high potency and cytotoxic characteristics for the pharmaceutical industry. Specifically, proteasome inhibitors, ADCs ( conjugation and fill/finishing) lipid-based formulations (nano and micro-emulsions, liposomal formulations) from development to clinical and commercial supply.